Fidaxomicin Use Rose Significantly Following CDI Guideline Update

Originally published by our sister publication Infectious Disease Special EditionBy Ethan CoveyFidaxomicin use is markedly increasing for treating Clostridioides difficile infection (CDI), according to a study presented at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas.figure img { width:100% !important; } figcaption { padding: 5px; background: transparent; word-wrap: normal; text-align: center; font-size:10px; line-height: 12px; }Source: Adobe Stock.The new an analysis of